Difference between revisions of "Pediatric Lomustine Dosing Chart"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
Line 1: Line 1:
 
{{#lst:Section editor transclusions|peds}}
 
{{#lst:Section editor transclusions|peds}}
<big>''This page contains studies that were specific to pediatric populations. For the more general AML page, follow [[Acute myeloid leukemia|this link]].</big>
 
 
{| class="wikitable" style="float:right; margin-right: 5px;"
 
{| class="wikitable" style="float:right; margin-right: 5px;"
 
|-
 
|-
Line 121: Line 120:
 
|20
 
|20
 
|}
 
|}
 +
 +
[[Category:General reference pages]]
 +
[[Category:Clinical pharmacology]]

Revision as of 12:29, 8 December 2021

Section editor transclusions

0 regimens on this page
0 variants on this page


COG ACNS0331 Lomustine Dosing Nomogram

Available Capsule Sizes

  • 10 mg
  • 40 mg
  • 100 mg


Body Surface Area (m2) Ideal Dose (75 mg/m2/day once daily) Actual Dose to be Given
2.0 150 mg, 150 mg
1.9 143 140
1.8 135 130
1.7 128 130
1.6 120 120
1.5 112 110
1.4 105 100
1.3 98 100
1.2 90 90
1.1 82 80
1.0 75 80
0.95 71 70
0.9 68 70
0.85 64 60
0.8 60 60
0.75 56 60
0.7 53 50
0.65 49 50
0.6 45 40
0.55 41 40
0.5 38 40
0.45 34 30
0.4 30 30
0.35 26 30
0.3 23 20